Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones

Chee, Y., Vickers, M., Stevenson, D., Holyoake, T. and Culligan, J. (2003) Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones. Leukemia, 17(3), pp. 634-635. (doi:10.1038/si.leu.2402842)

Full text not currently available from Enlighten.


Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Holyoake, Professor Tessa
Authors: Chee, Y., Vickers, M., Stevenson, D., Holyoake, T., and Culligan, J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Leukemia
ISSN:0887-6924

University Staff: Request a correction | Enlighten Editors: Update this record